Kester, Kent E.
Sanofi (United States)
2 papers on CoChatORCID 0000-0002-5056-0802
Most cited papers
- Verified
A Preliminary Evaluation of a Recombinant Circumsporozoite Protein Vaccine against Plasmodium falciparum Malaria
Stoute, J. A., Slaoui, M., Heppner, D. G., Momin, P., Kester, K. E., Desmons, P., Wellde, B. T., Garçon, N., Krzych, U., Marchand, M., et al. (1997) · New England Journal of Medicine
Malaria Research and ControlImmunotherapy and Immune Responses
Cited by 870
- Verified
The promise of mRNA vaccines: a biotech and industrial perspective
Jackson, N. A. C., Kester, K. E., Casimiro, D., Gurunathan, S., & DeRosa, F. (2020) · npj Vaccines
RNA Interference and Gene DeliverySARS-CoV-2 and COVID-19 Research
Cited by 498
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free